You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 57 No. 7, July 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (12)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Cerebrovascular Disease
 •Stroke
 •Cardiovascular System
 •Thrombolysis
 •Alert me on articles by topic

Usefulness of Triphasic Perfusion Computed Tomography for Intravenous Thrombolysis With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke

Kwang Ho Lee, MD; Soo Joo Lee, MD; Soo-Jin Cho, MD; Dong Gyu Na, MD; Hong Sik Byun, MD; Yong-Beom Kim, MD; Hee-Jeong Song, MD; In-Seon Jin, RN; Chin-Sang Chung, MD

Arch Neurol. 2000;57:1000-1008.

Background  Intravenous thrombolysis for acute ischemic stroke has been investigated in several clinical trials without enough information on collateral blood flow and perfusion deficit in the ischemic areas. The therapeutic time window varies from patient to patient depending on these factors. Triphasic perfusion computed tomography (TPCT) can provide this information as reliably as conventional angiography.

Objective  To assess the safety and efficacy of thrombolysis within 3 or 7 hours of stroke onset according to the extent of perfusion deficit on TPCT.

Methods  In 46 patients with acute middle cerebral artery (MCA) territory stroke, TPCT was performed with power injector–controlled, intravenous administration of contrast media after taking precontrast CT scans. Sequential scans of early, middle, and late phases were performed. The entire procedure took 5 minutes. Depending on collateral blood flow, the perfusion deficit on TPCT was graded as "severe perfusion deficit" or "moderate perfusion deficit." Twenty-nine patients were excluded based on clinical, laboratory, and TPCT findings. Seventeen patients were treated with an intravenous recombinant tissue-type plasminogen activator, 0.9 mg/kg. The 17 treated patients were divided into 2 groups: group 1 with small severe perfusion deficit (<=33% of the presumed MCA territory) and group 2 with medium-sized severe perfusion deficit (>33% but <=50% of the presumed MCA territory). The 13 patients in group 1 were treated within 7 hours of onset and the 4 patients in group 2 were treated within 3 hours.

Results  Initial mean National Institutes of Health Stroke Scale score was 12.1 (range, 6.0-20.0) in group 1 and 19.0 (range, 18.0-21.0) in group 2. The initial score correlated better with the total extent of moderate perfusion deficit and severe perfusion deficit than that of severe perfusion deficit alone. Mean time lapse to thrombolysis was 4.2 hours (range, 1.5-7.0 hours) in group 1 and 2.2 hours (range, 1.9-2.5 hours) in group 2. Eight patients (47%), 7 from group 1 and 1 from group 2, improved by 4 points or more from baseline Stroke Scale score within 24 hours of thrombolysis. Patients with moderate perfusion deficit of 50% or more of MCA territory (n = 4) had a better chance of early improvement than did those (n = 13) with moderate perfusion deficit of less than 50% (4 of 4 vs 4 of 13). No fatal hemorrhage occurred. Only 1 patient (6%) had symptomatic small basal ganglia hemorrhage after thrombolysis.

Conclusions  Thrombolysis can be safely performed within 3 or 7 hours of stroke onset according to the extent of severe perfusion deficit on TPCT. A larger extent of moderate perfusion deficit on TPCT may predict early improvement after thrombolysis.


From the Departments of Neurology (Drs K. H. Lee, S. J. Lee, Cho, Kim, Song, and Chung and Ms Jin) and Radiology (Drs Na and Byun), Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.


RELATED ARTICLE

Triphasic Perfusion Computed Tomography in Acute Middle Cerebral Artery Stroke: A Correlation With Angiographic Findings
Kwang Ho Lee, Soo-Jin Cho, Hong Sik Byun, Dong Gyu Na, Nak-Cheon Choi, Soo Joo Lee, In-Seon Jin, Te Gyu Lee, and Chin-Sang Chung
Arch Neurol. 2000;57(7):990-999.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Angiographic Assessment of Pial Collaterals as a Prognostic Indicator Following Intra-arterial Thrombolysis for Acute Ischemic Stroke
Christoforidis et al.
Am. J. Neuroradiol. 2005;26:1789-1797.
ABSTRACT | FULL TEXT  

Collateral Circulation
Liebeskind
Stroke 2003;34:2279-2284.
ABSTRACT | FULL TEXT  

Quantitative Cerebral Blood Flow Measurement with Dynamic Perfusion CT Using the Vascular-Pixel Elimination Method: Comparison with H215O Positron Emission Tomography
Kudo et al.
Am. J. Neuroradiol. 2003;24:419-426.
ABSTRACT | FULL TEXT  

Utility of Perfusion-Weighted CT Imaging in Acute Middle Cerebral Artery Stroke Treated With Intra-Arterial Thrombolysis:: Prediction of Final Infarct Volume and Clinical Outcome Editorial Comment: Prediction of Final Infarct Volume and Clinical Outcome
Lev et al.
Stroke 2001;32:2021-2028.
ABSTRACT | FULL TEXT  

Multisection Dynamic CT Perfusion for Acute Cerebral Ischemia: The "Toggling-table" Technique
Roberts et al.
Am. J. Neuroradiol. 2001;22:1077-1080.
ABSTRACT | FULL TEXT  

Perfusion Mapping Using Computed Tomography Allows Accurate Prediction of Cerebral Infarction in Experimental Brain Ischemia Editorial Comment
Nabavi et al.
Stroke 2001;32:175-183.
ABSTRACT | FULL TEXT  

CT Perfusion Scanning with Deconvolution Analysis: Pilot Study in Patients with Acute Middle Cerebral Artery Stroke
Eastwood et al.
Radiology 2002;222:227-236.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.